Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoru Taguchi

Showing results (61-70 of 137) with videos related to

Pageof 14
Sort By:
IJU Case Reports|March 4, 2025
Renal metastasis of hepatocellular carcinoma after living donor liver transplantationYo Nakamura, Jun Kamei, Ryo Tanaka, et al.
Scientific Reports|February 7, 2020
Author Correction: Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patientsSebastiano Buti, Pierre I Karakiewicz, Melissa Bersanelli, et al.
Scientific Reports|September 15, 2019
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patientsSebastiano Buti, Pierre I Karakiewicz, Melissa Bersanelli, et al.
Urologia Internationalis|January 28, 2021
Impact of Initial Computed Tomography Findings on Management of Atypical Urinary Cytology of the Upper Urinary TractKotaro Takemura, Taketo Kawai, Yusuke Sato, et al.
Kidney International Reports|February 14, 2022
Long-Term Outcomes of Longitudinal Efficacy Study With Tolvaptan in ADPKDEiji Higashihara, Kikuo Nutahara, Masayuki Itoh, et al.
Plos One|February 28, 2017
Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?Satoru Taguchi, Sebastiano Buti, Hiroshi Fukuhara, et al.
International Journal of Clinical Oncology|January 4, 2017
Skeletal-related events and prognosis in urothelial cancer patients with bone metastasisYusuke Tsuda, Tohru Nakagawa, Yusuke Shinoda, et al.
Kidney International Reports|September 21, 2020
Estimation of Changes in Kidney Volume Growth Rate in ADPKDEiji Higashihara, Hiroshi Fukuhara, John Ouyang, et al.
Japanese Journal of Clinical Oncology|November 27, 2014
Combination of docetaxel, ifosfamide and cisplatin (DIP) as a potential salvage chemotherapy for metastatic urothelial carcinomaShigenori Kakutani, Hiroshi Fukuhara, Satoru Taguchi, et al.
The Oncologist|February 15, 2026
A prospective external validation of the GRade, Age, Nodes and Tumor (GRANT) score in the ECOG-ACRIN EA8143 PROSPER trialSebastiano Buti, Se-Eun Kim, Michele Maffezzoli, et al.
Pageof 14

Showing results (61-70 of 137) with videos related to

Sort By:
Pageof 14
IJU Case Reports|March 4, 2025
Renal metastasis of hepatocellular carcinoma after living donor liver transplantationYo Nakamura, Jun Kamei, Ryo Tanaka, et al.
Scientific Reports|February 7, 2020
Author Correction: Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patientsSebastiano Buti, Pierre I Karakiewicz, Melissa Bersanelli, et al.
Scientific Reports|September 15, 2019
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patientsSebastiano Buti, Pierre I Karakiewicz, Melissa Bersanelli, et al.
Urologia Internationalis|January 28, 2021
Impact of Initial Computed Tomography Findings on Management of Atypical Urinary Cytology of the Upper Urinary TractKotaro Takemura, Taketo Kawai, Yusuke Sato, et al.
Kidney International Reports|February 14, 2022
Long-Term Outcomes of Longitudinal Efficacy Study With Tolvaptan in ADPKDEiji Higashihara, Kikuo Nutahara, Masayuki Itoh, et al.
Plos One|February 28, 2017
Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?Satoru Taguchi, Sebastiano Buti, Hiroshi Fukuhara, et al.
International Journal of Clinical Oncology|January 4, 2017
Skeletal-related events and prognosis in urothelial cancer patients with bone metastasisYusuke Tsuda, Tohru Nakagawa, Yusuke Shinoda, et al.
Kidney International Reports|September 21, 2020
Estimation of Changes in Kidney Volume Growth Rate in ADPKDEiji Higashihara, Hiroshi Fukuhara, John Ouyang, et al.
Japanese Journal of Clinical Oncology|November 27, 2014
Combination of docetaxel, ifosfamide and cisplatin (DIP) as a potential salvage chemotherapy for metastatic urothelial carcinomaShigenori Kakutani, Hiroshi Fukuhara, Satoru Taguchi, et al.
The Oncologist|February 15, 2026
A prospective external validation of the GRade, Age, Nodes and Tumor (GRANT) score in the ECOG-ACRIN EA8143 PROSPER trialSebastiano Buti, Se-Eun Kim, Michele Maffezzoli, et al.
Pageof 14